Italia markets closed

ILMN May 2024 125.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,8000-4,4000 (-70,97%)
In data: 02:05PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente6,2000
Aperto6,5200
Denaro2,2000
Lettera2,7000
Prezzo d'esercizio125,00
Scadenza2024-05-17
Min-Max giorno1,8000 - 3,7000
Contratto - Min-MaxN/D
Volume46
Open Interest913
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera